Gene: BAHCC1
Official Full Name: BAH domain and coiled-coil containing 1provided by HGNC
Gene Summary: Predicted to enable chromatin binding activity. Predicted to act upstream of or within chromatin organization; locomotory behavior; and neuron differentiation. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19494 | BAHCC1 Knockout cell line (HCT 116) | Human | BAHCC1 | 1:2~1:4 | Negative | Online Inquiry |
KO19495 | BAHCC1 Knockout cell line (HEK293) | Human | BAHCC1 | 1:3~1:6 | Negative | Online Inquiry |
KO19496 | BAHCC1 Knockout cell line (A549) | Human | BAHCC1 | 1:3~1:4 | Negative | Online Inquiry |
BAHCC1 Gene Knockout Cell Lines are advanced, genetically modified cell lines specifically engineered to lack the BAHCC1 gene. This knockout approach allows for the precise investigation of gene function and the elucidation of underlying genetic pathways. By employing CRISPR-Cas9 technology or similar genome editing methods, these cell lines serve as vital tools in understanding the biological roles of BAHCC1, a gene implicated in various cellular processes, including DNA damage response and cell proliferation.
The key function of BAHCC1 Gene Knockout Cell Lines lies in their ability to replicate the phenotypic consequences of gene deletion, thereby providing researchers with an ideal system to study the gene's effect on cellular growth, differentiation, and response to stressors. By comparing these knockout lines to their wild-type counterparts, scientists can dissect the molecular mechanisms orchestrated by BAHCC1 and explore its contributions to diseases, such as cancer and genetic disorders.
The scientific importance of these cell lines extends into both basic research and clinical applications. They enable mechanistic studies that shine light on potential therapeutic targets, facilitate drug testing, and provide a model for gene therapy experiments. Researchers can utilize these knockouts for high-throughput screening and biomarker discovery, significantly advancing personalized medicine and tailored treatment strategies.
Compared to other gene knockout models, our BAHCC1 Gene Knockout Cell Lines offer several unique selling points. They are rigorously validated for gene editing efficiency and phenotypic stability, ensuring reproducible results across diverse experimental conditions. Additionally, our product comes with comprehensive support and detailed characterization data, simplifying the integration into existing research workflows.
For researchers and clinicians aiming to further the understanding of gene function or develop targeted interventions, our BAHCC1 Gene Knockout Cell Lines represent a valuable asset. The ability to systematically dissect gene roles in disease models significantly streamlines biomedical research and accelerates the journey from bench to bedside.
With years of expertise in genetic engineering and cell line development, our company is dedicated to providing researchers with top-quality biological products that empower groundbreaking discoveries. Our commitment to innovation and scientific excellence ensures that you have access to the tools necessary to advance your research endeavors effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.